Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BODY Stock Summary
In the News
BODY Financial details
Company Rating
Sell
Market Cap
55.6M
Income
-152.64M
Revenue
527.11M
Book val./share
13.26
Cash/share
6.04
Dividend
-
Dividend %
-
Employees
737
Optionable
No
Shortable
Yes
Earnings
06 May 2024
P/E
-30.3
Forward P/E
-
PEG
-0.19
P/S
0.15
P/B
28.47
P/C
1.35
P/FCF
-2.43
Quick Ratio
0.25
Current Ratio
0.76
Debt / Equity
0.14
LT Debt / Equity
0.02
-
-
EPS (TTM)
-10.71
EPS next Y
-
EPS next Q
-
EPS this Y
3784.13%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-6.95%
Revenue Q/Q
-7.2%
EPS Q/Q
9372.73%
-
-
-
-
SMA20
12.5%
SMA50
-10%
SMA100
-10%
Inst Own
4.22%
Inst Trans
0.23%
ROA
-38%
ROE
-75%
ROC
-0.6%
Gross Margin
60%
Oper. Margin
-19%
Profit Margin
-24%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
6.31-28.5
52W High
-70.93%
52W Low
+35.67%
RSI
44
Rel Volume
0.62
Avg Volume
29K
Volume
18.09K
Perf Week
-9.56%
Perf Month
-9.76%
Perf Quarter
-
Perf Half Y
-46.62%
-
-
-
-
Beta
1.22
-
-
Volatility
0.49%, 0.6%
Prev Close
-15.21%
Price
8.14
Change
-14.14%
BODY Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.48 | 2.84 | 3.17 | 2.25 | 84.49 | |
Net income per share | 0.11 | -0.07 | -0.83 | -0.63 | -24.47 | |
Operating cash flow per share | 0.14 | 0.2 | -0.78 | -0.15 | -3.61 | |
Free cash flow per share | 0.06 | 0.08 | -1.06 | -0.24 | -4.67 | |
Cash per share | 0.14 | 0.2 | 0.41 | 0.28 | 6.04 | |
Book value per share | -0.04 | 0 | 1.4 | 0.69 | 13.26 | |
Tangible book value per share | -0.08 | -0.13 | 0.78 | 0.25 | 13.26 | |
Share holders equity per share | -0.04 | 0 | 1.4 | 0.69 | 13.26 | |
Interest debt per share | 0.17 | 0.14 | 0.03 | 0.16 | 0.39 | |
Market cap | 159.37B | 159.37B | 32.63B | 8.09B | 51.72M | |
Enterprise value | 159.38B | 159.35B | 32.53B | 8.05B | 29.64M | |
P/E ratio | 4.93K | -7.44K | -142.87 | -41.64 | -0.34 | |
Price to sales ratio | 210.87 | 184.54 | 37.35 | 11.68 | 0.1 | |
POCF ratio | 3.79K | 2.59K | -151.59 | -171.43 | -2.29 | |
PFCF ratio | 8.75K | 6.78K | -111.3 | -109.78 | -1.78 | |
P/B Ratio | -14.7K | 138.82K | 84.67 | 38.23 | 0.62 | |
PTB ratio | -14.7K | 138.82K | 84.67 | 38.23 | 0.62 | |
EV to sales | 210.88 | 184.52 | 37.24 | 11.63 | 0.06 | |
Enterprise value over EBITDA | 2.43K | 4.31K | -232.47 | -82.69 | -0.32 | |
EV to operating cash flow | 3.79K | 2.59K | -151.14 | -170.72 | -1.32 | |
EV to free cash flow | 8.75K | 6.78K | -110.97 | -109.32 | -1.02 | |
Earnings yield | 0 | 0 | -0.01 | -0.02 | -2.95 | |
Free cash flow yield | 0 | 0 | -0.01 | -0.01 | -0.56 | |
Debt to equity | -4.65 | 36.26 | 0.02 | 0.22 | 0.14 | |
Debt to assets | 0.17 | 0.12 | 0.01 | 0.1 | 0.04 | |
Net debt to EBITDA | 0.14 | -0.41 | 0.69 | 0.35 | 0.24 | |
Current ratio | 0.79 | 0.77 | 1.27 | 1.01 | 0.72 | |
Interest coverage | 23.9 | -13.88 | -378.25 | -51.43 | 10.3 | |
Income quality | 1.3 | -2.87 | 0.94 | 0.24 | 0.15 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.22 | 0 | -0.01 | 0 | 0 | |
Sales general and administrative to revenue | 0.08 | 0.08 | 0.09 | 0.11 | 0.11 | |
Research and developement to revenue | 0.11 | 0.11 | 0.14 | 0.15 | 0.14 | |
Intangibles to total assets | 0.04 | 0.11 | 0.27 | 0.3 | 0.31 | |
Capex to operating cash flow | -0.57 | -0.62 | 0.36 | 0.56 | 0.29 | |
Capex to revenue | -0.03 | -0.04 | -0.09 | -0.04 | -0.01 | |
Capex to depreciation | -0.53 | -0.86 | -1.31 | -0.35 | -0.1 | |
Stock based compensation to revenue | 0 | 0.01 | 0.02 | 0.03 | 0.05 | |
Graham number | 0.29 | 0.08 | 5.11 | 3.13 | 85.45 | |
ROIC | 0.36 | -0.3 | -0.47 | -0.65 | -0.94 | |
Return on tangible assets | 0.12 | -0.07 | -0.49 | -0.63 | -0.8 | |
Graham Net | -0.79 | -0.86 | -0.26 | -0.39 | -20.5 | |
Working capital | -33.97M | -50.87M | 63.14M | 1.81M | -45.93M | |
Tangible asset value | -23.7M | -38.95M | 213.85M | 78.17M | -2.41M | |
Net current asset value | -174.25M | -186.06M | 47.15M | -45.4M | -74.81M | |
Invested capital | -4.65 | 36.26 | 0.02 | 0.22 | 0.14 | |
Average receivables | 0 | 1.19M | 1.04M | 1.05M | 11.11M | |
Average payables | 0 | 22.75M | 38.68M | 33.16M | 14.3M | |
Average inventory | 0 | 52.54M | 99.04M | 93.4M | 39.52M | |
Days sales outstanding | 0.73 | 0.36 | 0.51 | 0.46 | 14.79 | |
Days payables outstanding | 28.66 | 42.36 | 53.73 | 20.3 | 19.07 | |
Days of inventory on hand | 68.95 | 95.53 | 147.41 | 61.16 | 44.68 | |
Receivables turnover | 497.88 | 1.01K | 713.18 | 799.31 | 24.68 | |
Payables turnover | 12.74 | 8.62 | 6.79 | 17.98 | 19.14 | |
Inventory turnover | 5.29 | 3.82 | 2.48 | 5.97 | 8.17 | |
ROE | -2.98 | -18.67 | -0.59 | -0.92 | -1.84 | |
Capex per share | -0.08 | -0.12 | -0.28 | -0.09 | -1.05 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.48 | 0.47 | 0.43 | 0.42 | 19.08 | |
Net income per share | -0.15 | -0.09 | -0.08 | -0.11 | -10.42 | |
Operating cash flow per share | -0.03 | -0.03 | -0.02 | 0 | -1.27 | |
Free cash flow per share | -0.04 | -0.04 | -0.03 | 0 | -1.45 | |
Cash per share | 0.27 | 0.23 | 0.21 | 0.14 | 6.04 | |
Book value per share | 0.69 | 0.61 | 0.53 | 0.46 | 13.26 | |
Tangible book value per share | 0.25 | 0.08 | 0.02 | -0.05 | 13.26 | |
Share holders equity per share | 0.69 | 0.61 | 0.53 | 0.46 | 13.26 | |
Interest debt per share | 0.16 | 0.16 | 0.16 | 0.11 | -0.69 | |
Market cap | 8.11B | 7.45B | 6.58B | 4.56B | 51.72M | |
Enterprise value | 8.08B | 7.43B | 6.57B | 4.55B | 29.64M | |
P/E ratio | -45.13 | -63.81 | -63.94 | -34.87 | -0.2 | |
Price to sales ratio | 54.74 | 51.42 | 48.8 | 35.53 | 0.43 | |
POCF ratio | -792.89 | -946.79 | -1.01K | -21.1K | -6.5 | |
PFCF ratio | -601.41 | -660.14 | -811.84 | -6.65K | -5.73 | |
P/B Ratio | 38.34 | 39.3 | 39.39 | 32.3 | 0.62 | |
PTB ratio | 38.34 | 39.3 | 39.39 | 32.3 | 0.62 | |
EV to sales | 54.52 | 51.28 | 48.7 | 35.49 | 0.25 | |
Enterprise value over EBITDA | -278.78 | -1.43K | -507.34 | -261.57 | -0.25 | |
EV to operating cash flow | -789.6 | -944.25 | -1.01K | -21.07K | -3.73 | |
EV to free cash flow | -598.92 | -658.37 | -810.33 | -6.64K | -3.28 | |
Earnings yield | -0.01 | 0 | 0 | -0.01 | -1.26 | |
Free cash flow yield | 0 | 0 | 0 | 0 | -0.17 | |
Debt to equity | 0.22 | 0.24 | 0.28 | 0.23 | 0.14 | |
Debt to assets | 0.1 | 0.11 | 0.12 | 0.09 | 0.04 | |
Net debt to EBITDA | 1.16 | 3.84 | 0.95 | 0.31 | 0.19 | |
Current ratio | 1.01 | 0.96 | 0.83 | 0.76 | 0.72 | |
Interest coverage | -13.33 | -9.46 | -10.21 | -13.98 | 1.03 | |
Income quality | 0.23 | 0.27 | 0.25 | 0.01 | 0.12 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0.01 | |
Payout ratio | 0 | 0 | -0.01 | 0 | -0.01 | |
Sales general and administrative to revenue | 0.13 | 0.12 | 0.09 | 0.12 | 0.11 | |
Research and developement to revenue | 0.14 | 0.13 | 0.14 | 0.15 | 0.15 | |
Intangibles to total assets | 0.3 | 0.39 | 0.41 | 0.45 | 0.31 | |
Capex to operating cash flow | 0.32 | 0.43 | 0.25 | 2.17 | 0.14 | |
Capex to revenue | -0.02 | -0.02 | -0.01 | 0 | -0.01 | |
Capex to depreciation | -0.2 | -0.21 | -0.15 | -0.05 | -0.04 | |
Stock based compensation to revenue | 0.03 | 0.07 | 0.02 | 0.05 | 0.04 | |
Graham number | 1.5 | 1.14 | 0.99 | 1.04 | 55.78 | |
ROIC | -0.11 | -0.09 | -0.11 | -0.16 | -0.17 | |
Return on tangible assets | -0.14 | -0.12 | -0.11 | -0.17 | -0.34 | |
Graham Net | -0.39 | -0.42 | -0.43 | -0.48 | -20.5 | |
Working capital | 1.81M | -6.51M | -32.28M | -42.09M | -45.93M | |
Tangible asset value | 78.17M | 25.91M | 7.17M | -15.07M | -2.41M | |
Net current asset value | -45.4M | -54.43M | -64.73M | -75.58M | -74.81M | |
Invested capital | 0.22 | 0.24 | 0.28 | 0.23 | 0.14 | |
Average receivables | 868.5K | 1.35M | 1.72M | 1.54M | 11.42M | |
Average payables | 15.9M | 17.35M | 15.03M | 14.71M | 13.39M | |
Average inventory | 61.03M | 51.18M | 45.83M | 37.56M | 28.36M | |
Days sales outstanding | 0.53 | 1.14 | 1.07 | 1.04 | 16.15 | |
Days payables outstanding | 25.41 | 28.15 | 22.93 | 27.25 | 21.3 | |
Days of inventory on hand | 76.57 | 81.17 | 74.76 | 53.69 | 49.91 | |
Receivables turnover | 171.09 | 78.79 | 84.24 | 86.42 | 5.57 | |
Payables turnover | 3.54 | 3.2 | 3.92 | 3.3 | 4.23 | |
Inventory turnover | 1.18 | 1.11 | 1.2 | 1.68 | 1.8 | |
ROE | -0.21 | -0.15 | -0.15 | -0.23 | -0.79 | |
Capex per share | -0.01 | -0.01 | -0.01 | 0 | -0.17 |
BODY Frequently Asked Questions
What is The Beachbody Company, Inc. stock symbol ?
The Beachbody Company, Inc. is a US stock , located in El segundo of Ca and trading under the symbol BODY
What is The Beachbody Company, Inc. stock quote today ?
The Beachbody Company, Inc. stock price is $8.14 today.
Is The Beachbody Company, Inc. stock public?
Yes, The Beachbody Company, Inc. is a publicly traded company.